Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-07-28 | New | $188,187,915 | $188,187,915 | Equity Only | 06b | SEC link |
2023-11-03 | Amended | $104,999,994 | $54,999,997 | Equity Only | 06b | SEC link |
2023-07-19 | New | $49,999,997 | $49,999,997 | Equity Only | 06b | SEC link |
2022-11-10 | New | $11,999,999 | $11,999,999 | Equity Only | 06b | SEC link |
2021-03-10 | New | $29,999,999 | $29,999,999 | Equity Only | 06b | SEC link |
2019-09-04 | New | $15,999,999 | $15,999,999 | Equity Only | 06b | SEC link |
2019-03-22 | Amended | $5,000,000 | $0 | Equity Only | 06b | SEC link |
2019-03-08 | New | $5,000,000 | $5,000,000 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Peter Bisgaard | Director |
Erin Foff | Executive |
Timothy Garnett | Director |
Jonathan Gillis | Executive |
Kristopher Hanson | Executive |
Anatol Kreitzer | Executive |
Christopher A Kroeger | Director, Executive |
Jim Lillie | Executive |
James Lillie | Executive |
Nanna Luneborg | Director |
Charmaine Lykins | Executive |
Robert Malenka | Director |
George Pavlov | Director |
Vishwas Setia | Executive |
Jim Trenkle | Director |
Maria Walker | Director |